WHITSETT, North Carolina, Nov. 1, 2016 /PRNewswire/ -- medi USA announced the international expansion of the restiffic® compressive foot wrap for the treatment of Restless Legs Syndrome (RLS) in the United Kingdom. restiffic offers unique, affordable, drug-free therapy for patients suffering from RLS and can now be purchased online at www.restiffic.co.uk.
Video - http://youtu.be/Fe62f6qKGXc
restiffic is available through medi UK, a partner company of medi USA, based in Hereford, United Kingdom. Ian Grant, Director of medi UK, said, "Restless Legs Syndrome patients in the United Kingdom have been eagerly awaiting a clinically proven, drug-free treatment for their symptoms, and we are excited to share restiffic with them."
restiffic was launched in the United States in June 2016 and has been met with enthusiastic reviews from both patients and clinicians alike. One satisfied patient testifies that her legs "remained calm from the moment [she] put restiffic on," and that she would "recommend restiffic to anyone who suffers from RLS."
Since its launch in June 2016, restiffic has received countless inquiries from residents of the United Kingdom about restiffic's availability in their country, which has a vibrant and engaged RLS community. restiffic will continue to expand its distribution elsewhere in Europe and Latin America later in 2016 and into 2017. Inquiries about its availability in specific countries may be sent to email@example.com.
Media contact: Maggie Moriarty, firstname.lastname@example.org, 1-336-449-4440
SOURCE medi USA